Last reviewed · How we verify
NCT05547139
Impact of Extended CPAP on Bronchopulmonary Dysplasia
NA trial testing Protocolized weaning of respiratory support in Bronchopulmonary Dysplasia in 20 participants. Completed in 31 July 2024.
31 May 2024
Quick facts
| Lead sponsor | Christiana Care Health Services |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 10 October 2022 |
| Primary completion | 31 May 2024 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Protocolized weaning of respiratory support
Conditions studied
- Bronchopulmonary Dysplasia — all drugs for Bronchopulmonary Dysplasia →
- Prematurity — all drugs for Prematurity →
Sponsor
Christiana Care Health Services — full company profile →
Who can join
Adults 22 Weeks to 30 Weeks, any sex, with Bronchopulmonary Dysplasia or Prematurity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this pilot study is to compare if keeping infants on CPAP (continuous positive airway pressure) support for an extended period of time until they are 32 weeks corrected gestational age or 1250 grams (approximately 2 pounds and 12 ounces) will decrease their degree of lung disease as compared to weaning their respiratory support to HFNC (high flow nasal cannula).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05547139
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bronchopulmonary Dysplasia
Currently open trials in the same condition.
- NCT06589245 — Inhaled Ciclesonide Study in Preterm Infants · Phase 1 · recruiting
- NCT06512935 — Ventilator Pressure and Optimization of Compliance and Hemodynamics · NA · recruiting
- NCT06534359 — Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia · NA · recruiting
- NCT06808997 — Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preter · recruiting
- NCT06897839 — Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) · Phase 2, PHASE3 · recruiting
Other Christiana Care Health Services trials
Trials by the same sponsor.
- NCT06807684 — Abnormal Connectivity Involving the Social Reciprocity Network in Autism and the Impact of Neurostimulation in Mitigatin · NA · recruiting
- NCT06268431 — Oxytocin Rest to Reduce Cesarean Delivery · NA · recruiting
- NCT05232994 — Metformin and Esomeprazole For Preterm Pre-eclampsia · Phase 1 · unknown
- NCT04739683 — Cervical Ripening With Foley Bulb Versus Dilapan-S at Home · NA · withdrawn
- NCT05209269 — Work of Breathing in Term Infants · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05547139 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Christiana Care Health Services
- Last refreshed: 29 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05547139.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing